Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126100901 | 12610090 | 1 | I | 20160422 | 20160718 | 20160801 | 20160801 | EXP | GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2016RR-121145 | RANBAXY | 68.00 | YR | F | Y | 0.00000 | 20160801 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126100901 | 12610090 | 1 | PS | Zoledronic acid | ZOLEDRONIC ACID | 1 | Unknown | U | 202746 | ||||||||||
| 126100901 | 12610090 | 2 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Oral | AT NIGHT. | U | U | 0 | 100 | MG | ||||||
| 126100901 | 12610090 | 3 | C | ATENOLOL. | ATENOLOL | 1 | Oral | U | U | 0 | 25 | MG | |||||||
| 126100901 | 12610090 | 4 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | U | U | 0 | 20 | MG | |||||||
| 126100901 | 12610090 | 5 | C | HYDROCORTISONE. | HYDROCORTISONE | 1 | Topical | APPLY THINLY TWICE A DAY AS DIRECTED. | U | U | 0 | ||||||||
| 126100901 | 12610090 | 6 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | Oral | 100 AND 50 MICROGRAM TABLETS. | U | U | 0 | 150 | UG | ||||||
| 126100901 | 12610090 | 7 | C | MIRTAZAPINE. | MIRTAZAPINE | 1 | Oral | AT NIGHT | U | U | 0 | 45 | MG | ||||||
| 126100901 | 12610090 | 8 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | IN THE MORNING. | U | U | 0 | 20 | MG | ||||||
| 126100901 | 12610090 | 9 | C | PARACETAMOL | ACETAMINOPHEN | 1 | Oral | U | U | 0 | 1 | G | |||||||
| 126100901 | 12610090 | 10 | C | PERINDOPRIL | PERINDOPRIL | 1 | Oral | U | U | 0 | 8 | MG | |||||||
| 126100901 | 12610090 | 11 | C | LYRICA | PREGABALIN | 1 | Oral | U | U | 0 | 300 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126100901 | 12610090 | 1 | Product used for unknown indication |
| 126100901 | 12610090 | 2 | Product used for unknown indication |
| 126100901 | 12610090 | 3 | Product used for unknown indication |
| 126100901 | 12610090 | 4 | Product used for unknown indication |
| 126100901 | 12610090 | 5 | Product used for unknown indication |
| 126100901 | 12610090 | 6 | Product used for unknown indication |
| 126100901 | 12610090 | 7 | Product used for unknown indication |
| 126100901 | 12610090 | 8 | Product used for unknown indication |
| 126100901 | 12610090 | 9 | Product used for unknown indication |
| 126100901 | 12610090 | 10 | Product used for unknown indication |
| 126100901 | 12610090 | 11 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126100901 | 12610090 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126100901 | 12610090 | Asthenia | |
| 126100901 | 12610090 | Balance disorder | |
| 126100901 | 12610090 | Headache | |
| 126100901 | 12610090 | Influenza like illness | |
| 126100901 | 12610090 | Myalgia | |
| 126100901 | 12610090 | Pyrexia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126100901 | 12610090 | 1 | 20160421 | 20160421 | 0 |